97 related articles for article (PubMed ID: 8764587)
1. Neuronal release of serotonin in the cerebellum of behaving rats: an in vivo microdialysis study.
Mendlin A; Martín FJ; Rueter LE; Jacobs BL
J Neurochem; 1996 Aug; 67(2):617-22. PubMed ID: 8764587
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic input is required for increases in serotonin output produced by behavioral activation: an in vivo microdialysis study in rat forebrain.
Mendlin A; Martín FJ; Jacobs BL
Neuroscience; 1999; 93(3):897-905. PubMed ID: 10473255
[TBL] [Abstract][Full Text] [Related]
3. Changes in forebrain serotonin at the light-dark transition: correlation with behaviour.
Rueter LE; Jacobs BL
Neuroreport; 1996 Apr; 7(5):1107-11. PubMed ID: 8804061
[TBL] [Abstract][Full Text] [Related]
4. A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations.
Rueter LE; Jacobs BL
Brain Res; 1996 Nov; 739(1-2):57-69. PubMed ID: 8955925
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
6. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity.
Sharp T; Bramwell SR; Clark D; Grahame-Smith DG
J Neurochem; 1989 Jul; 53(1):234-40. PubMed ID: 2470860
[TBL] [Abstract][Full Text] [Related]
7. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat.
Adell A; Artigas F
Br J Pharmacol; 1998 Nov; 125(6):1361-7. PubMed ID: 9863668
[TBL] [Abstract][Full Text] [Related]
8. A critical review of 5-HT brain microdialysis and behavior.
Rueter LE; Fornal CA; Jacobs BL
Rev Neurosci; 1997; 8(2):117-37. PubMed ID: 9344182
[TBL] [Abstract][Full Text] [Related]
9. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
Hjorth S; Sharp T
J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761
[TBL] [Abstract][Full Text] [Related]
10. In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin.
Adell A; Carceller A; Artigas F
J Neurochem; 1993 May; 60(5):1673-81. PubMed ID: 7682600
[TBL] [Abstract][Full Text] [Related]
11. Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia.
Wilkinson LO; Auerbach SB; Jacobs BL
J Neurosci; 1991 Sep; 11(9):2732-41. PubMed ID: 1715390
[TBL] [Abstract][Full Text] [Related]
12. Seizure activity and hyperthermia potentiate the increases in dopamine and serotonin extracellular levels in the amygdala during exposure to d-amphetamine.
Tor-Agbidye J; Yamamoto B; Bowyer JF
Toxicol Sci; 2001 Mar; 60(1):103-11. PubMed ID: 11222877
[TBL] [Abstract][Full Text] [Related]
13. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin.
Chen NH; Reith ME
J Neurochem; 1995 Apr; 64(4):1585-97. PubMed ID: 7891086
[TBL] [Abstract][Full Text] [Related]
14. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
Fornal CA; Metzler CW; Gallegos RA; Veasey SC; McCreary AC; Jacobs BL
J Pharmacol Exp Ther; 1996 Aug; 278(2):752-62. PubMed ID: 8768728
[TBL] [Abstract][Full Text] [Related]
15. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
Assié MB; Koek W
Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
[TBL] [Abstract][Full Text] [Related]
16. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
17. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.
Haddjeri N; De Montigny C; Curet O; Blier P
Eur J Pharmacol; 1998 Feb; 343(2-3):179-92. PubMed ID: 9570466
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
Sharp T; Bramwell SR; Grahame-Smith DG
Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
Matos FF; Korpinen C; Yocca FD
Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
